Showing results (2031-2040 of 2,316) with videos related to

Sort By:
Pageof 232
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
Journal of Medicinal Chemistry|June 6, 2025
Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase InhibitorsLin Du, Brice A P Wilson, William J Moore, et al.
BMC Nephrology|June 2, 2025
Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKIAudrey A Shi, Anna Simone Andrawis, Aditya Biswas, et al.
Papua and New Guinea Medical Journal|February 6, 2014
Male circumcision for HIV prevention in Papua New Guinea: a summary of research evidence and recommendations for public health following a national policy forumA Vallely, D J MacLaren, W Kaleva, et al.
Plos Computational Biology|September 27, 2021
Optima TB: A tool to help optimally allocate tuberculosis spendingLara Goscé, Gerard J Abou Jaoude, David J Kedziora, et al.
Journal of Medical Genetics|August 3, 2006
STK11 status and intussusception risk in Peutz-Jeghers syndromeN Hearle, V Schumacher, F H Menko, et al.
The Journal of Experimental Medicine|May 6, 2015
STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and functionRobert P Wilson, Megan L Ives, Geetha Rao, et al.
Scientific Data|December 17, 2025
Scalable cyberinfrastructure for experimental NMR dataJeffrey C Hoch, Katherine Henzler-Wildman, Arthur S Edison, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2017
Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and miceDanny Halim, Michael P Wilson, Daniel Oliver, et al.
Journal of Clinical Lipidology|December 25, 2015
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2Terry A Jacobson, Kevin C Maki, Carl E Orringer, et al.
Pageof 232